By Dr. Philip Goglia
As GLP-1 medications become more widely used for metabolic health and weight management, users are having conversations about more than just the weight loss and glucose control. Some people have reported experiencing emotional changes such as anxiety, mood shifts, restlessness and a general feeling of being “off”.
While researchers are still studying why some have had these experiences, early theories point toward the way that these medications interact with both the brain and the digestive system.
GLP-1 Receptors Exist in the Brain Too
Most people think that GLP-1 medications act primarily on appetite and digestion but there are GLP-1 receptors also located throughout the brain. These receptors are involved in pathways that are connected to our appetite regulation, stress response, reward behavior, and emotional signaling.
Because semaglutide activates GLP-1 receptors, some individuals may be more sensitive to its neurological effects. This does not mean that the medication directly “causes” the issues, but it may influence the stress signaling responses in people who are already predisposed to anxiety or other nervous system sensitivities. This can feel like increased restlessness, irritability, or generalized anxious feelings that were not present before treatment.
The Gut-Brain Connection
Another thing to consider is the close relationship between the digestive system and the nervous system, often called the gut-brain axis. Semaglutide is known for significantly slowing gastric emptying, which can create prolonged feelings of fullness, nausea, bloating, or other digestive discomfort in some users.
That physical discomfort can have a powerful effect on emotional well-being. When digestion feels “off” for extended periods of time, the body can respond by being in a heightened state of stress. This can feel like nervousness or anxiety, especially during dose increases or periods of appetite suppression. Sometimes, people don’t realize that the body responding to ongoing gastrointestinal discomfort and disrupted eating patterns can feel like anxiety.
Why Tirzepatide May Feel Different
This is where some users have reported that tirzepatide works differently from semaglutide. This is because tirzepatide activates both the GLP-1 and GIP receptors instead of focusing just on GLP-1 activity. While researchers are still studying how GIP affects the brain and nervous system, some theories suggest that it may be helpful in balancing some of the more intense effects associated with GLP-1 activation alone.
This could be why some have reported feeling more emotionally “steady” on tirzepatide compared to semaglutide. Others have reported fewer digestive side effects, smoother energy levels, and less emotional change during treatment.
It’s important to remember that responses to GLP-1 treatment remain highly individualized. Some have a more preferred response to semaglutide whereas others say that they feel significantly better after switching to tirzepatide.
The psychological effects associated with GLP-1 medications are still being researched. There is no universal experience that applies to everyone and factors like digestive side effects, stress and sleep levels, nutrition, and pre-existing anxiety can all influence how a person responds to treatment.
As more and more people choose GLP-1 plans for their own wellness, conversations around these side effects are likely to continue. It is important to pay attention to any physical and psychological changes you may experience during treatment and, should you experience persistent anxiety or mood changes, talk about it with your healthcare provider.